My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 511

    1.

    Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens.

    Woerle HJ, Mariuz PR, Meyer C, Reichman RC, Popa EM, Dostou JM, Welle SL, Gerich JE.

    Diabetes. 2003 Apr;52(4):918-25.PMID: 12663461 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.

    Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S.

    J Clin Endocrinol Metab. 2000 Jan;85(1):35-41.PMID: 10634360 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children.

    Bitnun A, Sochett E, Babyn P, Holowka S, Stephens D, Read S, King SM.

    AIDS. 2003 Jun 13;17(9):1319-27.PMID: 12799553 [PubMed - indexed for MEDLINE]Related articles

    4.

    Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells.

    Haugaard SB, Andersen O, Dela F, Holst JJ, Storgaard H, Fenger M, Iversen J, Madsbad S.

    Eur J Endocrinol. 2005 Jan;152(1):103-12.PMID: 15762193 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

    Behrens G, Dejam A, Schmidt H, Balks HJ, Brabant G, Körner T, Stoll M, Schmidt RE.

    AIDS. 1999 Jul 9;13(10):F63-70.PMID: 10416516 [PubMed - indexed for MEDLINE]Related articles

    6.

    Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways.

    van der Valk M, Bisschop PH, Romijn JA, Ackermans MT, Lange JM, Endert E, Reiss P, Sauerwein HP.

    AIDS. 2001 Nov 9;15(16):2093-100.PMID: 11684928 [PubMed - indexed for MEDLINE]Related articles

    7.

    Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection.

    Tebas P, Yarasheski K, Henry K, Claxton S, Kane E, Bordenave B, Klebert M, Powderly WG.

    AIDS Res Hum Retroviruses. 2004 Jun;20(6):589-94.PMID: 15242534 [PubMed - indexed for MEDLINE]Related articles

    8.

    The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.

    Lo JC, Mulligan K, Noor MA, Schwarz JM, Halvorsen RA, Grunfeld C, Schambelan M.

    J Clin Endocrinol Metab. 2001 Aug;86(8):3480-7.PMID: 11502767 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of raloxifene on insulin sensitivity, beta-cell function, and hepatic insulin extraction in normal postmenopausal women.

    Nagamani M, Szymajda A, Sepilian V, Urban RJ, Gilkison C.

    Fertil Steril. 2008 Mar;89(3):614-9. Epub 2007 Jun 25.PMID: 17586504 [PubMed - indexed for MEDLINE]Related articles

    10.

    Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).

    Vigouroux C, Gharakhanian S, Salhi Y, Nguyen TH, Chevenne D, Capeau J, Rozenbaum W.

    Diabetes Metab. 1999 Sep;25(3):225-32.PMID: 10499191 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution.

    Meininger G, Hadigan C, Laposata M, Brown J, Rabe J, Louca J, Aliabadi N, Grinspoon S.

    Metabolism. 2002 Feb;51(2):260-6.PMID: 11833059 [PubMed - indexed for MEDLINE]Related articles

    12.

    Insulin sensitivity and beta-cell function in protease inhibitor-treated and -naive human immunodeficiency virus-infected children.

    Bitnun A, Sochett E, Dick PT, To T, Jefferies C, Babyn P, Forbes J, Read S, King SM.

    J Clin Endocrinol Metab. 2005 Jan;90(1):168-74. Epub 2004 Oct 13.PMID: 15483082 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia.

    Reeds DN, Yarasheski KE, Fontana L, Cade WT, Laciny E, DeMoss A, Patterson BW, Powderly WG, Klein S.

    Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E47-E53. Epub 2005 Aug 23.PMID: 16118251 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia.

    Enoksson S, Caprio SK, Rife F, Shulman GI, Tamborlane WV, Sherwin RS.

    J Clin Endocrinol Metab. 2003 Apr;88(4):1503-11.PMID: 12679430 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells.

    Haugaard SB, Andersen O, Storgaard H, Dela F, Holst JJ, Iversen J, Nielsen JO, Madsbad S.

    Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E677-85. Epub 2004 May 18.PMID: 15149949 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

    Walli R, Herfort O, Michl GM, Demant T, Jäger H, Dieterle C, Bogner JR, Landgraf R, Goebel FD.

    AIDS. 1998 Oct 22;12(15):F167-73.PMID: 9814858 [PubMed - indexed for MEDLINE]Related articles

    17.

    Lipid metabolism and insulin resistance in cirrhosis.

    Kaye GL, Kruszynska YT, Harry DS, Heslop K, Johnston DG, McIntyre N.

    J Hepatol. 1994 Jun;20(6):782-91.PMID: 7930479 [PubMed - indexed for MEDLINE]Related articles

    18.

    Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study.

    Saint-Marc T, Partisani M, Poizot-Martin I, Rouviere O, Bruno F, Avellaneda R, Lang JM, Gastaut JA, Touraine JL.

    AIDS. 2000 Jan 7;14(1):37-49.PMID: 10714566 [PubMed - indexed for MEDLINE]Related articles

    19.

    Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy.

    Blümer RM, van Vonderen MG, Sutinen J, Hassink E, Ackermans M, van Agtmael MA, Yki-Jarvinen H, Danner SA, Reiss P, Sauerwein HP.

    AIDS. 2008 Jan 11;22(2):227-36.PMID: 18097225 [PubMed - indexed for MEDLINE]Related articles

    20.

    Short-term low-dose growth hormone administration in subjects with impaired glucose tolerance and the metabolic syndrome: effects on beta-cell function and post-load glucose tolerance.

    Yuen K, Wareham N, Frystyk J, Hennings S, Mitchell J, Fryklund L, Dunger D.

    Eur J Endocrinol. 2004 Jul;151(1):39-45.PMID: 15248820 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity